Deutsche Bank’s Cartesian Therapeutics RNAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$77.1K Hold
7,424
﹤0.01% 3331
2025
Q1
$97.8K Buy
7,424
+3,786
+104% +$49.9K ﹤0.01% 3175
2024
Q4
$65.2K Hold
3,638
﹤0.01% 3334
2024
Q3
$58.6K Hold
3,638
﹤0.01% 3291
2024
Q2
$98.3K Buy
3,638
+1,444
+66% +$39K ﹤0.01% 3076
2024
Q1
$42.8K Hold
2,194
﹤0.01% 3377
2023
Q4
$45.4K Hold
2,194
﹤0.01% 3382
2023
Q3
$69.8K Buy
+2,194
New +$69.8K ﹤0.01% 3293
2022
Q4
Sell
-18,576
Closed -$914K 3933
2022
Q3
$914K Buy
18,576
+85
+0.5% +$4.18K ﹤0.01% 2022
2022
Q2
$727K Sell
18,491
-7,129
-28% -$280K ﹤0.01% 2366
2022
Q1
$946K Sell
25,620
-198
-0.8% -$7.31K ﹤0.01% 2374
2021
Q4
$2.53M Buy
25,818
+5,827
+29% +$570K ﹤0.01% 1831
2021
Q3
$2.5M Sell
19,991
-2,212
-10% -$276K ﹤0.01% 1924
2021
Q2
$2.79M Sell
22,203
-3,335
-13% -$418K ﹤0.01% 1921
2021
Q1
$3.47M Buy
25,538
+1,386
+6% +$188K ﹤0.01% 1783
2020
Q4
$2.2M Buy
24,152
+22,944
+1,899% +$2.09M ﹤0.01% 1883
2020
Q3
$90K Buy
1,208
+167
+16% +$12.4K ﹤0.01% 3545
2020
Q2
$89K Buy
+1,041
New +$89K ﹤0.01% 3448
2020
Q1
Sell
-215
Closed -$15K 4443
2019
Q4
$15K Sell
215
-388
-64% -$27.1K ﹤0.01% 4199
2019
Q3
$31K Buy
603
+309
+105% +$15.9K ﹤0.01% 4003
2019
Q2
$15K Sell
294
-1,119
-79% -$57.1K ﹤0.01% 4529
2019
Q1
$100K Sell
1,413
-2,824
-67% -$200K ﹤0.01% 4167
2018
Q4
$337K Buy
4,237
+2,874
+211% +$229K ﹤0.01% 3513
2018
Q3
$636K Buy
1,363
+196
+17% +$91.5K ﹤0.01% 3595
2018
Q2
$463K Buy
1,167
+549
+89% +$218K ﹤0.01% 3819
2018
Q1
$188K Sell
618
-441
-42% -$134K ﹤0.01% 4092
2017
Q4
$311K Sell
1,059
-459
-30% -$135K ﹤0.01% 3701
2017
Q3
$830K Buy
1,518
+1,072
+240% +$586K ﹤0.01% 3092
2017
Q2
$264K Buy
446
+404
+962% +$239K ﹤0.01% 3657
2017
Q1
$17K Sell
42
-66
-61% -$26.7K ﹤0.01% 4181
2016
Q4
$54K Buy
+108
New +$54K ﹤0.01% 4060